The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection
暂无分享，去创建一个
M. Weinstein | K. Freedberg | J. Salomon | B. Schackman | B. Linas | D. Barter | J. Leff | C. Horsburgh | A. Kim | S. Assoumou | J. Morgan | M. Pho | C. Horsburgh | Devra M. Barter | S. A. Assoumou